Development and external validation of a machine learning model for cardiovascular risk prediction in individuals with chronic lung disease: Evidence from CHARLS and ELSA - Takeaways - MDSpire

Development and external validation of a machine learning model for cardiovascular risk prediction in individuals with chronic lung disease: Evidence from CHARLS and ELSA

  • By

  • Ankang Zhu

  • Shuai Wei

  • Haobo Wang

  • Shaodong Liu

  • Yang Li

  • Xiaojie Pan

  • Xingcai Gao

  • Xing Lin

  • June 8, 2026

  • 0 min

Share

  • 1

    Chronic lung diseases (CLD) significantly increase cardiovascular disease (CVD) risk, contributing to high morbidity and mortality rates.

  • 2

    Current CVD risk assessment tools inadequately address the unique characteristics of patients with CLD, necessitating tailored prediction models.

  • 3

    Machine learning (ML) algorithms, particularly XGBoost, show promise in improving CVD risk prediction accuracy for the CLD population.

  • 4

    The study utilized data from CHARLS and ELSA to develop and validate an ML-based CVD risk prediction model for patients with CLD.

  • 5

    An interactive online assessment tool was created to facilitate practical application of the CVD risk prediction model in clinical settings.

Original Source(s)

Development and external validation of a machine learning model for cardiovascular risk prediction in individuals with chronic lung disease: Evidence from CHARLS and ELSA

  • by Ankang Zhu, Shuai Wei, Haobo Wang, Shaodong Liu, Yang Li, Xiaojie Pan, Xingcai Gao, Xing Lin

  • June 8, 2026

Related Content

RNA modifications shape innate immunity and cellular adaptation during bacterial respiratory infection

Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study

When seasonal structure dominates: rethinking causal attribution in environmental epidemiology